Corline Biomedical AB (STO:CLBIO)

Corline Biomedical AB Revenue

Corline Biomedical AB had revenue of 4.31M SEK in the quarter ending March 31, 2026, with 93.48% growth. This brings the company's revenue in the last twelve months to 10.67M, down -23.40% year-over-year. In the year 2025, Corline Biomedical AB had annual revenue of 8.59M, down -50.29%.

• Revenue (ttm): 10.67M
• Revenue Growth: -23.40%
• P/S Ratio: 43.37
• Revenue / Employee: 820.46K
• Employees: 13
• Market Cap: 462.56M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	8.59M	-8.69M	-50.29%
Dec 31, 2024	17.27M	-18.25M	-51.37%
Dec 31, 2023	35.52M	2.93M	8.98%
Dec 31, 2022	32.59M	15.40M	89.55%
Dec 31, 2021	17.19M	2.12M	14.05%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 12, 2026

Data Sources Report a data error